huMAN SRL
The score of huMAN shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +1977 % Total assets +1110 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
huMAN's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Jun 2026
- Year ended 31 Dec 2024filed on 25 Jul 2025
- Year ended 31 Dec 2023filed on 01 Jul 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
huMAN's financial analysis
- Solvency95.7%sector median: 38.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of huMAN
huMAN's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0777.905.257
- VAT number
- BE0777905257
- Peppol
- Registered · 0208:0777905257 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 01 Dec 2021
- Registered office
- 6280 Gerpinnes
- Latest accounts
- 2025 · filed on 21 Jun 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
huMAN (SRL) has been based in Gerpinnes since 2021, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 53,042 € and equity of 178,126 €; its revenue is not published. Its solvency stands at 95.7%, above the median of its sector (38.7%).
Companies similar to huMAN
Companies in the same business, of comparable size and area, outside its group.
- Yaro Preclinical Consulting Manufacture of basic pharmaceutical products Turnhout · balance sheet 158,481 €
- Make IT Work Consulting Manufacture of basic pharmaceutical products Hamois · balance sheet 220,980 €
- Clinical Research Vanackere Manufacture of basic pharmaceutical products Tielt-Winge · balance sheet 263,927 €
- MDT Services & Technologies Manufacture of basic pharmaceutical products Lontzen · balance sheet 102,386 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- Pneoo Business and other management consultancy activities Vosselaar · balance sheet 145,836 €
- Ansorius Retail sale of pharmaceutical products Bastogne · balance sheet 174,823 €
Frequently asked questions about huMAN
What is the revenue of huMAN?
huMAN files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of huMAN?
In Belgium, the VAT number is the company number prefixed with BE: BE0777905257 for huMAN, if the company is VAT-registered. Its company number (CBE) is 0777.905.257.
Where is the registered office of huMAN?
According to the CBE register, the registered office of huMAN is in 6280 Gerpinnes.
What is the equity of huMAN?
At the close of the 2025 financial year, the equity of huMAN amounts to 178,126 €, a solvency of 95.7% of total assets.
Who manages huMAN?
The register lists 1 active mandates at huMAN. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of huMAN
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →